Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
MedPlus Health Services Ltd. ( (IN:MEDPLUS) ) has issued an update.
MedPlus Health Services Ltd. announced that its subsidiary, Optival Health Solutions Private Limited, has received a suspension order for a drug license at a store in Tamil Nadu. The suspension, issued by the Drugs Control Administration, Zone-IV, Tamil Nadu, is for three days and is expected to result in a potential revenue loss of approximately Rs 2.25 lakhs. This development could impact the company’s operations in the region, highlighting regulatory challenges in maintaining compliance with drug and cosmetics regulations.
More about MedPlus Health Services Ltd.
MedPlus Health Services Ltd. operates in the healthcare industry, primarily focusing on providing pharmaceutical products and health services. The company is based in Hyderabad, India, and is known for its extensive network of retail pharmacy outlets across the country.
YTD Price Performance: -11.59%
Average Trading Volume: 7,571
Current Market Cap: 90.91B INR
Find detailed analytics on MEDPLUS stock on TipRanks’ Stock Analysis page.